Navigation Links
Tutogen Medical, Inc. to Report First Quarter Fiscal 2008 Financial Results
Date:1/29/2008

ALACHUA, Fla., Jan. 29 /PRNewswire-FirstCall/ -- Tutogen Medical, Inc. (Amex: TTG), a leading manufacturer of sterile biological implant products made from human (allograft) and animal (xenograft) tissue, will report financial results for the first quarter ended December 31, 2007 on Wednesday, February 6, 2008. The Company will discuss these results in a conference call scheduled for 10:00 a.m. ET, on February 6, 2008.

Interested parties can access the call by dialing (888) 408-9532 or (706) 679-5064 or by accessing the web cast at http://www.tutogen.com/Investor.aspx. A replay of the call will be available at (800) 642-1687 or (706) 645-9291, conference ID number: 33119197 for 3 days following the call, and the web cast can be accessed at http://www.tutogen.com/Investor.aspx for 30 days.

About Tutogen Medical, Inc.

Tutogen Medical, Inc. manufactures sterile biological implant products made from human (allograft) and animal (xenograft) tissue. Tutogen utilizes its proprietary Tutoplast Process(R) of tissue preservation and viral inactivation to manufacture and deliver sterile bio-implants used in spinal/trauma, urology, dental, ophthalmology, and general surgery procedures. The Company's Tutoplast(R) products are sold and distributed worldwide by Zimmer Spine and Zimmer Dental, subsidiaries of Zimmer Holdings, Inc., Davol Inc., a subsidiary of C.R. Bard Inc., the Mentor Corporation, Coloplast Corp., IOP, Inc. and through independent distributors internationally. For more information, visit the Company's web site at http://www.tutogen.com. <
'/>"/>

SOURCE Tutogen Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Medical, technological advances prompt updating of nuclear medicine technologists scope of practice
2. Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM)
3. Cardiva Medical, Inc. to Present at the UBS 2007 Global Life Science Conference With the Announcement of FDA 510(K) Clearance of its Newest Device: The Boomerang Catalyst II System(TM)
4. Thermage, Inc. Announces Distribution Agreement With Eclipse Medical, Ltd.
5. Medical, Behavioral Woes Can Drive Dogs to Bite
6. ReBuilder Medical Technologies, Inc. Announces UK Demand for Safe Molluscum Contagiosum Treatment Leads to Distribution Agreement with UFFE Medical, LTD. Expected 10% Sales Increase.
7. Sedgwick CMS and UnitedHealth Group to Develop Integrated Disability, Medical, Workers Compensation and Leave Administration Services for Employers
8. Emmaus Medical, Inc. Enters Into Sub-License Agreement for Treatment of Short Bowel Syndrome
9. XCPT(TM) Patient Engagement and Communication Software Signs Representation Agreement with Lifecore Biomedical, Inc. (Nasdaq: LCBM)
10. Gary Tschautscher of Nonin Medical, Inc. Receives CEO of 2007 for North American Patient Monitoring From Frost & Sullivan
11. Cardiva Medical, Inc. Appoints Two New Officers: Malcolm Farnsworth as Vice President of Finance and Chief Financial Officer and Tara Zerby as Vice President of Business Development and Marketing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...ll/ -- Quest Diagnostics Incorporated (NYSE: DGX...ting, information and services, announced that it ...are Conference in New York City today, December 2,...duled to begin at 4:00 p.m. Eastern Time. , ...irm its 2008 guidance for revenue growth of greate...
(Date:12/2/2008)... December 1, 2008, issue of Clinical Cancer Resea...ncer Research, show lapatinib benefits women with ...-negative breast cancer or those who express EGRF ...a misclassification of metastatic breast cancer pa...le from receiving optimal therapy. , Lapatinib,...
(Date:12/2/2008)..., Cost and Energy Efficient Information Infrastruc...re/ -- EMC Corporation (NYSE: EMC ), the world l...ay announced that the Daughters of Charity Health ...spanning the California coast, has consolidated st...ity functions to deliver new online clinical syste...
(Date:12/2/2008)...Emdeon, a leading provider of,revenue and payment...ustry,announced today the launch of an important...are. Emdeon unveiled the U.S. Healthcare Efficienc...blish a national reference for,tracking and measu...ased,system to an electronic one. , "Throu...
Breaking Medicine News(10 mins):Health News:Quest Diagnostics to Speak at the 20th Annual Piper Jaffray Healthcare Conference 2Health News:HER2 levels may aid in treatment selection for metastatic breast cancer 2Health News:Daughters of Charity Health System Improves IT Efficiency and Accelerates Time-to-Treatment with EMC 2Health News:Daughters of Charity Health System Improves IT Efficiency and Accelerates Time-to-Treatment with EMC 3Health News:Daughters of Charity Health System Improves IT Efficiency and Accelerates Time-to-Treatment with EMC 4Health News:Emdeon Convenes Industry Forum to Monitor Business Efficiency in Healthcare 2Health News:Emdeon Convenes Industry Forum to Monitor Business Efficiency in Healthcare 3Health News:Emdeon Convenes Industry Forum to Monitor Business Efficiency in Healthcare 4
...ple in a Tamil Nadu village and over 60 doctors ar...tes complications.// A medical technology company,... with the Tirunelveli Medical College at the Ariya...ere. "At present, there is little testing done to...
...have been on an all time high in the United Kingdo...n the rising temperature and pollution levels. //A...iod from 15th to 19th July, the temperatures were ...gen dioxide pollution, which is known to trigger a...
...n their way home after a month-long training in tr...nt in India will surely help improve life in war-t...mastered will help my people in Iraq," Wafa Esmaee...from Bangalore, where she was among 43 Iraqis who ...
...n developed by Georgia Tech researchers to decode ...s with other cells and reacts //to a broad spectru...ld help to better create drugs that are capable of...g human diseases. Most sophisticated tools curren...
Other Medicine News:Health News:Villagers in Tamil Nadu Take Part in Diabetes Pilot Project 2Health News:Sensor Images Show Soaring Temperature and Pollution Levels in UK 2Health News:Yoga and Meditation Comes in Aid of Iraqis to Rid of Trauma 2Health News:Yoga and Meditation Comes in Aid of Iraqis to Rid of Trauma 3Health News:Cell Behavior Better Understood with Nano Probe 2Health News:Cell Behavior Better Understood with Nano Probe 3
(Date:12/2/2008)...erapeutics, Inc., a,privately held biopharmaceuti...se 3 trials evaluating its lead investigational pr...ts. HZT-501, a novel, proprietary fixed-dose,comb...e, demonstrated a,statistically significant reduc...mmatory drug (NSAID)-induced upper gastrointestina...
(Date:12/1/2008)...announced that an oral,presentation of prelimina...,trial of TG101348 in myeloproliferative disease p...ociety of Hematology (ASH) Meeting. , , Det...tle: A Phase I Study of TG101348, an ...Selective Inhibitor, in Patients with, ...
(Date:12/1/2008)... , ROCHESTER, Minn., Dec. 1 /PRNewswire-USNews...e of the drug therapy etanercept ineffective in tr...of the liver caused by excessive consumption of al...he December issue of Gastroenterology ( http://w...Additional audio and video resources, including ex...
(Date:12/1/2008)...al Incorporated (Nasdaq: VICL ) announced today ...om Merck & Co., Inc. based on Merck,s planned ...tigational plasmid DNA (pDNA) cancer vaccine. The ...ivery technology and encodes human telomerase reve... separate license agreement. , , "The bread...
Breaking Medicine Technology:Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 2Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 3Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 4Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 2Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 3Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial 2Robotic Surgeons From Around the World Attend One of a Kind Conference by Global Robotics Institute at Florida Hospital 14446 1Robotic Surgeons From Around the World Attend One of a Kind Conference by Global Robotics Institute at Florida Hospital 14446 2Blood Thinner Contaminant Traced to Chinese Plant 14444 1Blood Thinner Contaminant Traced to Chinese Plant 14444 2Blood Thinner Contaminant Traced to Chinese Plant 14444 3Penn researchers identify first sex chromosome gene involved in meiosis and male infertility 14441 1Penn researchers identify first sex chromosome gene involved in meiosis and male infertility 14441 2White Men With Chest Pains Treated Fastest in ERs 14437 1White Men With Chest Pains Treated Fastest in ERs 14437 2White Men With Chest Pains Treated Fastest in ERs 14437 3
...SIGA Technologies, Inc.,(NASDAQ: SIGA) announced t...guinea pig trial of its lead Lassa fever virus dru...ty Level 4 conditions at,the U.S. Army Medical Res...by Dr. Kathleen Cashman under the supervision of D...hemorrhagic fever,viruses at USAMRIID for over 12 ...
... data on leading,drug-eluting stent portfolio, NAT... Boston,Scientific Corporation today announced the...announcements at the annual Paris,Course on Revasc...,to 25 in Barcelona, Spain. , "We will be announci...d registries, adding to the knowledge base for tre...
Other Medicine Technology:SIGA Passes First Hurdle with Lassa Fever Antiviral ST-193 2SIGA Passes First Hurdle with Lassa Fever Antiviral ST-193 3SIGA Passes First Hurdle with Lassa Fever Antiviral ST-193 4Boston Scientific Announces Schedule for EuroPcr 2007 2Boston Scientific Announces Schedule for EuroPcr 2007 3Boston Scientific Announces Schedule for EuroPcr 2007 4Boston Scientific Announces Schedule for EuroPcr 2007 5
...se ECG Systems offer clinical features to meet any...e functionality for paperless storage. Flexible, a...PCE Exercise ECG software turns any computer into ...y to connect with leading EMR systems, the family ...
The Quinton Q-Stress Cardiac Stress Monitor combines Quinton algorithms, unique baseline wander and muscle artifact filters, and 8000 samples per second to provide the highest ECG fidelity in the ind
The CASE 8000 is one of the first, true point-of-care clinical information systems for the exercise environment. By combining the accuracy of our premiere exercise ECG system with the information acc
...cise stress system, the Quest, combines innovative...ic capabilities. Combined with a 15" color monitor...e screen to program or select specific functions. ..., highlighting the step usually taken next. No mor...
Medicine Products: